Aratana, Elanco Announce Global Strategic Collaboration

Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY) and Aratana Therapeutics, Inc. (NASDAQ: PETX), today announced a licensing agreement for Aratana’s FDA-approved therapeutic for the control of pain and inflammation associated with osteoarthritis in dogs.